aztreonam

Aztreonam A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.

[1. Abbreviation for azidothymidine.

Molecular Formula: C₁₃H₁₇N₅O₈S₂

InChI: InChI=1/C13H17N5O8S2/c1-5-7(10(20)18(5)28(23,24)25)16-9(19)8(6-4-27-12(14)15-6)17-26-13(2,3)11(21)22/h4-5,7H,1-3H3,(H2,14,15)(H,16,19)(H,21,22)(H,23,24,25)/b17-8+/t5-,7-/m0/s1/f/h16,21H,14H3

InChIKey: InChIKey=WZPBZJONDBGPKJ-LFXDGDFIDM
SMILES: CC1C(C(=O)N1S(=O)(=O)[O-])NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)[NH3+]

Names:
    Azactam (TN)
    Azactam
    AZT
    Aztreonam (JP15/USP)
    aztreonam
    D00240
    (2S,3S)-3-[[(2E)-2-(2-azaniumyl-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-2-methyl-4-oxo-azetidine-1-sulfonate
    78110-38-0

Registries:
    PubChem CID 5362041
    PubChem ID 7847306